SKILLEMALL.ai

AC assess-target-drug-bd-opportunities-ls

Integrate target biology, disease rationale, drug pipeline, clinical, patent, scientific, regulatory, company, and transaction evidence for target or targeted-asset R&D and business-development decisions. Use for target initiation reviews, asset or modality opportunity screens, partnering theses, target landscape updates, and evidence-based go/no-go conditions.

ClawHub Agent Skills author: yuanzhian-patsnap v1.0.0 MIT-0 5 files body ≈ 3 367 tokens Open the sourceclawhub.ai analyzed 3 d ago

Integrate target biology, disease rationale, drug pipeline, clinical, patent, scientific, regulatory, company, and transaction evidence for target or…

As a process C 55/100 · Has gaps — weak spots: result and completion, failures and branches, progress reporting

ProcedureInfrastructureAI and agentsWriting and documentstype and topics are labelled automatically from the skill text
JSON
Technical rating
A
93/100
safety, quality, tests
Safety 60%
100
Quality 40%
83
Run on models
none yet
Process rating
C
55/100
Has gaps
Result and completion w 14
0
Failures and branches w 10
0
Progress reporting w 2
0
the three weakest of ten parameters · all ten

How to improve

    For the model run — optional
    • Your own cases (evals/evals.json, 4–6 real requests with expected answers): the full check would then run those instead of a model-drafted suite.
    • A spec.yaml with trigger phrases and assertions — a behaviour contract for CI; `skilltest init` writes a template.

    Guard findings · 0

    ✓ No critical or high findings

    Files scanned: 5. Evidence is masked. Grey chips explain why severity was lowered.

    Against the Agent Skills spec

    • note frontmatter-key unknown frontmatter key "copyright"

    Process rating: all ten parameters 55/100

    • 0Result and completion. Does not say what the result is
    • 0Failures and branches. Linear process with no failure handling
    • 0Progress reporting. Says nothing while it works
    • 50When it triggers. No condition that starts the skill
    • 60Tools and files. Uses tools (web) that frontmatter does not declare
    • 70Inputs and preconditions. Inputs and preconditions are listed
    • 85Steps. 147 steps, 1 vague phrases
    • 100Consistency. Name and required fields are in place
    • 100Execution cost. Instruction body is 3367 tokens
    • 100Running it twice. No mutating operations
    • low 10 top-level sections: this looks like several domains in one skill

    Everything here is measured from the skill text rather than judged by a model, so the numbers are checkable. A parameter weighs more when it is a more common reason for the process to stall.

    Quality signals

    • +5Description has no quoted example phrases that should trigger the skill
    • +4Description does not say when NOT to use the skill (false activations)
    • +3Output format is not stated: the model decides each time
    • +4No input/output examples
    • +1No license
    • +2Single-language instructions
    • +3Description length 363: enough signal without eating the budget
    • +4Structure: 22 headings
    • +3Step-by-step instructions: 147 items
    • +4Reference files are cited in the instructions (1 of 1)

    Quality base 70; lint remarks subtract, signals add up to 100. Result: 83.

    External checks

    ClawHub: clean
    This skill is a transparent, documentation-only workflow for creating evidence-backed drug target and business-development assessment reports.
    LLM: benign (high) · VirusTotal: · 13 Aug 2026